Transgenic mice overexpressing SR-BI was protected against atherosclerosis, while SR-BI deficiency could increase atherosclerosis, ignoring the increased levels of HDL-C, likely resulted from decreased hepatic delivery as well as clearance of cholesterol (8–13). The gene discussed is SCARB1; the disease is atherosclerosis.